scispace - formally typeset
H

Hak Soo Choi

Researcher at Harvard University

Publications -  220
Citations -  15460

Hak Soo Choi is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Fluorophore. The author has an hindex of 51, co-authored 194 publications receiving 12994 citations. Previous affiliations of Hak Soo Choi include Korea University & Japan Advanced Institute of Science and Technology.

Papers
More filters
Journal ArticleDOI

Renal clearance of quantum dots.

TL;DR: This study has precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles and provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.
Journal ArticleDOI

Design considerations for tumour-targeted nanoparticles

TL;DR: This study shows that quantum dots functionalized with high-affinity small-molecule ligands that target tumours can also be cleared by the kidneys if their hydrodynamic diameter is less than this value, which sets an upper limit of 5-10 ligands per quantum dot for renal clearance.
Journal ArticleDOI

Rapid translocation of nanoparticles from the lung airspaces to the body

TL;DR: It is demonstrated that nanoparticles with hydrodynamic diameter less than ≈34 nm and a noncationic surface charge translocate rapidly from the lung to mediastinal lymph nodes and the bloodstream, and then be subsequently cleared by the kidneys.
Journal ArticleDOI

Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation:

TL;DR: The principles of NIR fluorescence imaging are introduced, existing NIRfluorescence imaging systems are analyzed, and the key parameters that guide contrast agent development are discussed.
Journal ArticleDOI

Targeted zwitterionic near-infrared fluorophores for improved optical imaging

TL;DR: This fluorophore provides a much-improved SBR when targeted to cancer cells or proteins by conjugation with a cyclic RGD peptide, fibrinogen or antibodies, and suggests that introducing zwitterionic properties into targeted fluorophores may be a general strategy for improving the SBR in diagnostic and therapeutic applications.